Buy (ALXA) FDA approval coming, short term price target is $18.00!
Buy these three stocks and count your millions !
These stocks will make you rich!
Our marketing campaigns are producing serious gains!! All three of these stocks will rise 300% each! Insiders are accumulating shares before the big news! Companies are now buyout targets! These low share prices will not last long!
(FDA) approvals and (USPTO) approvals coming!
Hemispherx Biopharma, Inc. (HEB) -NYSE
PDUFA on or before February 1st 2013
Short term price target $3.75
Rosetta Genomics, Ltd. (ROSG) -Nasdaq
USPTO Patents approved in all 50 states and global
Short term price target is $25.50
Alexza Pharmaceuticals Inc. (ALXA) -Nasdaq
PDUFA December on or before 21st 2012
Short term price target is $17.00